Log In
Print
BCIQ
Print
Print this Print this
 

rilapladib (SB 659032)

Also known as: 659032

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSmall molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2)
Molecular Target Lipoprotein-associated phospholipase A2 (PLA2G7) (PAFAH) (Lp-PLA2)
Mechanism of ActionLipoprotein-associated phopholipase A2 (Lp-PLA2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today